Andrew J Murphy Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

REGN Quotes by TradingView

Andrew J Murphy is EVP Research of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 49,074 shares of REGN, which is worth approximately $34.4 Million. The most recent transaction as insider was on Jul 14, 2020, when has been sold 3,929 shares (Common Stock) at a price of $621.5 per share, resulting in proceeds of $2,441,873. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.1K
4.14% 3M change
1.59% 12M change
Total Value Held $34.4 Million

ANDREW J MURPHY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 14 2020
SELL
Open market or private sale
$2,441,873 $621.5 p/Share
3,929 Reduced 8.14%
44,331 Common Stock
Jul 14 2020
SELL
Open market or private sale
$1,510,728 $634.76 p/Share
2,380 Reduced 5.37%
41,951 Common Stock
Jul 13 2020
SELL
Payment of exercise price or tax liability
$4,175,050 $623.98 p/Share
6,691 Reduced 12.18%
48,260 Common Stock
Jul 13 2020
SELL
Open market or private sale
$5,016,800 $627.1 p/Share
8,000 Reduced 16.02%
41,951 Common Stock
Jul 13 2020
BUY
Exercise of conversion of derivative security
$398,190 $30.63 p/Share
13,000 Added 19.13%
54,951 Common Stock
AJM

Andrew J Murphy

EVP Research
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on REGN